SANDERS TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE INC CO WEILL CORNEL

EIN: 463673346 501(c)(3) Medical Research

NEW YORK, NY

Total Revenue
$16,577,142
Total Expenses
$16,577,142
Total Assets
$7,307,418
Net Assets
N/A
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2013
Legal Domicile
DE
Principal Officer
PETER T MEINKE PHD
Phone
2123278704
Tax Period
2024-01-01 to 2024-12-31

SANDERS TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE INC CO WEILL CORNEL, founded in 2013, is a mid-sized nonprofit in the Medical Research sector that reported $16.6M in total revenue in fiscal year 2024. Revenue decreased 11% compared to the prior year.

Mission

TO FURTHER AND IMPROVE HEALTH AND THE DIAGNOSIS, PREVENTION AND TREATMENT OF DISEASE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $330,000
Program Service Revenue $16,160,405
Investment Income $86,737
Other Revenue $0
TOTAL REVENUE $16,577,142

Expense Breakdown

Grants Paid $0
Salaries & Benefits $7,847,293
Fundraising Expenses $0
Program Expenses $15,393,838
Other Expenses $8,729,849
TOTAL EXPENSES $16,577,142

Year-over-Year Comparison

2024 2023 Change
Revenue $16,577,142 $18,703,204 -0.1%
Expenses $16,577,142 $18,703,204 -0.1%
Net Income $0 $0 N/A
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
9
Independent Members
N/A
Employees
32
Volunteers
N/A

Governance Policies

✓ Conflict of Interest Policy
✓ Whistleblower Policy
✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$1,290,196
Total Directors
9
$15,696,654
Key Employees
0
$0
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
SELWYN VICKERS MD BOARD MEMBER 0.50
Director
$0 $342,150 $6,979,162
RICHARD P LIFTON MD PHD BOARD MEMBER 0.50
Director
$0 $285,349 $1,593,942
ROBERT HARRINGTON MD BOARD MEMBER 0.50
Director
$0 $43,901 $2,710,554
BARRY COLLER MD BOARD MEMBER 0.50
Director
$0 $123,955 $840,772
BARBARA HEMPSTEAD MD BOARD MEMBER 0.50
Director
$0 $50,274 $860,912
DAVID SCHEINBERG MD PHD BOARD MEMBER 0.50
Director
$0 $71,956 $757,643
CARL NATHAN MD BOARD MEMBER 0.50
Director
$0 $68,608 $693,861
NATHANIEL HEINTZ PHD BOARD MEMBER 0.50
Director
$0 $138,395 $683,784
DEREK TAN PHD BOARD MEMBER 0.50
Director
$0 $85,209 $576,024
PETER T MEINKE PHD SANDERS DIRECTOR 40.00
Officer
$627,542 $68,608 $696,150
MICHAEL P VITALE TREASURER 0.50
Officer
$0 $144,581 $594,046
MANUEL BACA VICE PRESIDENT, BIOLOGICS 40.00
Highest
$403,018 $71,836 $474,854
NIGEL LIVERTON PHD VICE PRESIDENT, CHEMISTRY 40.00
Highest
$290,336 $61,066 $351,402
PAUL BALDERES SR. DIRECTOR 40.00
Highest
$280,506 $61,100 $341,606
PATRICIA AHA VICE PRESIDENT, OPRATIONS 40.00
Highest
$300,813 $60,121 $360,934
SANDRA LORBER VICE PRESIDENT, FINANCE 40.00
Highest
$255,246 $47,104 $302,350
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $16,577,142 $16,577,142 $7,307,418 No data
2023 $18,703,204 $18,703,204 $7,953,486 No data
2022 $17,034,275 $17,034,275 $8,782,111 No data
2021 $16,905,997 $16,905,997 $5,819,394 No data
2020 $16,570,714 $16,832,694 $3,922,902 $-261,980
2019 $18,048,093 $18,394,143 $5,948,211 $-346,050
2018 $20,132,913 $20,380,760 $8,198,806 $-247,847
Explore More Nonprofits
→Top 100 Nonprofits in New York →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare SANDERS TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE INC CO WEILL CORNEL with other nonprofits in New York and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.